Perucca E, Richens A
J Neurol Neurosurg Psychiatry. 1980 Jun;43(6):540-5. doi: 10.1136/jnnp.43.6.540.
The hypothesis that phenytoin may antagonise the antidiuretic effect of carbamazepine has been examined by comparing the free water clearance response to a standard water load in 36 patients stabilised on different drug regimes. The diuretic response to the water load was significantly greater in patients receiving chronic treatment with carbamazepine and phenytoin in combination than in matched control subjects receiving carbamazepine as a single drug. Acute administration of phenytoin (1,100 mg), however, had no significant influence on carbamazepine-induced antidiuresis. Evidence is presented that reversal of the antidiuretic effect of carbamazepine by chronic phenytoin administration is secondary to a marked reduction of the serum carbamazepine concentration during combined therapy. These results suggest that the risk of developing water intoxication is greater in patients receiving carbamazepine alone than in those receiving phenytoin in combination. Since the antidiuretic effect is correlated with the serum carbamazepine concentration rather than with the prescribed daily dose, monitoring the serum level of the drug is likely to provide the best rational approach to the prevention of excessive water retention.
通过比较36例使用不同药物方案稳定治疗的患者对标准水负荷的自由水清除率反应,研究了苯妥英可能拮抗卡马西平抗利尿作用的假说。接受卡马西平和苯妥英联合长期治疗的患者对水负荷的利尿反应明显大于接受卡马西平单药治疗的匹配对照受试者。然而,急性给予苯妥英(1,100毫克)对卡马西平引起的抗利尿作用没有显著影响。有证据表明,长期给予苯妥英导致卡马西平抗利尿作用的逆转是联合治疗期间血清卡马西平浓度显著降低的继发结果。这些结果表明,单独接受卡马西平治疗的患者发生水中毒的风险高于接受苯妥英联合治疗的患者。由于抗利尿作用与血清卡马西平浓度相关而非与规定的每日剂量相关,监测药物的血清水平可能为预防过多水潴留提供最佳合理方法。